Andrew J. Schwab, Director: Camp4 Therapeutics CAMP Buy · Filed 24/10/15

Trade details

Type: Insider buy
Amount: $9,999,990
Shares · price: 909,090 sh · $11.00 a share
Held after: 2,625,145 sh
Stock: Camp4 Therapeutics CAMP
Person: Andrew J. SchwabDirector
Trade date: 24/10/15
Filed: 24/10/15
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 29 insiders
Holding change: +53.0%

Camp4 Therapeutics trades, last 26 weeks

What else happened in Camp4 Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/15~24/11/14

Andrew J. Schwab's recent trades

Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$184.9K
114,851 sh
$184.9K
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$45.6K
27,612 sh
$45.6K
Filed 09/24
Traded 09/22
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$7,290
4,528 sh
$7,290
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$1,795
1,088 sh
$1,795
Filed 09/24
Traded 09/22
Andrew J. Schwab10% Owner
SellEntrada Therapeutics
Sell
Entrada Therapeutics
TRDA
$1.8M
200,000 sh
$1.8M
Filed 25/11/18
Traded 25/11/14